nemvaleukin alfa,alks 4230
alkermes
['melanoma', 'artistry-6', 'nemvaleukin']
#cedarssinaicancer at #asco22. artistry-6: nemvaleukin alfa monotherapy in patients with advanced mucosal and cutaneous #melanoma with co-authors dr. omid hamid &amp; dr. inderjit mehmi is being presented. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.